NCT04588064View on ClinicalTrials.gov

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Lung Adenocarcinoma18F-FDG68Ga-FAPIPET/CT
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI PET/CT scan

Each subject receives a single intravenous injection of 68Ga-FAPI, and undergo PET/CT imaging within the specified time.

Trial Locations (1)

0086-361000

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER

NCT04588064 - 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma | Biotech Hunter | Biotech Hunter